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SUMMARY
Endogenous uveitis is an important cause of blindness in
young adults. The need for a comprehensive search for an
aetiological 'antigen' is stressed. A source of adjuvant,
disturbance in host immunology and any associated syn-
dromes are also sought. Treatment then involves elimina-
tion of 'antigen', suppression of host hypersensitivity and
the enhanced vascular permeability, and improvement of
host resistance. The value of antihistamine and anti-
serotonin drugs in successful treatment is emphasised.
S. Afr. med. l., 50, 286 (1976).
Endogenous uveitis is a major cause of blindness and is
particularly important because it affects mainly young
adults. The average case can be treated empirically with
steroids and atropine and a broad-spectrum antibiotic
with good immediate effect. However, the patient so
treated in whom the disorder recurs, will not do so well,
and the chances of establishing an aetiology are then
much smaller. In this article we present a rational scheme
of management for uveitis.
APPROACH AND METHODS
Our approach is to identify the cause, or the combination
of factors, responsible for the uveitis. This is not always
possible, but by using a variety of clinical, biochemical
and bacteriological investigations, and by interpreting
these in the light of standard immunological theory, we
are able to investigate and treat endogenous uveitis in a
rational manner. We do a complete examination of the
patient at a special uveitis clinic. Our approach is based
on the general proposition that the le!lion of endogenous
uveitis is caused by an 'antigen' which may range from
hapten, virus, fungus, protozoon through to the patient's
bodily constituents. In addition, the patient's immuno-
logical response is influenced by adjuvants and various
general diseases. These factors can be conveniently summa-
rised by the equation:
antigen dose x multiplying power x
host hypersensitivity
size of lesion = ------------------
body resistance
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We therefore attempt to identify a source of antigen, a
source of adjuvant, disturbed immunological response of
the host and any associated syndromes (Table I).
Table II gives the spectrum of diseases which are
commonly associated with uveitis in the Western Cape.
TABLE I. UVEITIS INVESTIGATIONS
X-ray examination
Skull
Sinuses
Teeth
Chest
Lumbar sacral spine
Indirect tests
ESR, FBC
Immuno-electrophoresis
C-reactive protein
Liver functions
Urea, uric acid
Mucoprotein
Specific tests
VDRL
FTA-ABS }for syphilis
RPR
Gonococcal complement fixation
ASO-titre
Widal
Weil-Felix
Brucella
Paul-Bunell
Histoplasmosis
Leptospirosis
Toxoplasmosis
Tuberculin skin tests: tine, Mantoux
Specialist opinion
ENT
Ur,ology
Gynaecology
Internal medicine
Treatment
Treatment involves elimination of antigen, suppression
of host hypersensitivity and improvement of host resistance.
Although the antigen may be easily and quickly identified,
e.g. toxoplasmosis or syphilis, it is very important to
suppress the inflammation as soon as possible, in order
to prevent the development of auto-antibodies to the lens,
the retina and possibly the uvea, or, what is probably more
important, the accumulation of large numbers of immuno-
cytes within the eye tissue.
TABLE 11. RESULTS OF INVESTIGATION OF 122 CASES OF ENDOGENOUS UVEITIS
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3
2
2
Proven
Retinal detachment
Sarcoidosis
Bronchopneumonia
7
8
6
2
2
2
1
1
1
Strongly presumptive
Syphilis
Tuberculosis
Toxoplasmosis
Angle closure glaucoma
Herpes simplex
Fuchs heterochromia
Rickettsia
Salmonellosis
Gonorrhoea
32
15
1
5
3
2
1
Presumptive
Strep. infections
Syphilis
Toxoplasmosis
Tooth abscess
Amoebiasis
Typhoid
Lens-induced
26
Idiopathic
26 59 30 7
Steroids, which are the mainstay of anti-inflammatory
therapy, are effective in preventing the development of
immunocytes from small Iymphocytes, but once immuno-
cytes have developed, they are much less effective.
We have found that when steroids alone have failed
to control intra-ocular inflammation, inhibitors of serotonin
and histamine have been effective.
CASE REPORTS (Table Ill)
Case 1
A woman whose right eye had been destroyed during
childhood, developed a grumbling uveitis in the remaining
eye at the age of 55 years. After 7 years the condition
produced a dislocated lens and uncontrollable glaucoma.
Two Scheie operations failed to control the pressure, but
control was attained by a Molteno implant inserted in
May 1970. However, the uveitis remained active, and
by December 1973 it was uncontrolled in spite of systemic
treatment with steroids and subconjunctival Depo-Medrol
every 3 weeks. Side-effects of steroids - hypertension.
gastric discomfort and collapse of a vertebra - were
becoming intolerable. A trial of methysergide maleate
(Deseril) and chlorpheniramine maleate (Chlortrimeton)
was commenced and she has responded dramatically so far.
The patient has been discharged and is treated as an out-
patient. A relapse followed on one occasion when she
ran out of medication, but for the last 12 months her
uveitis has been controlled with Chlortrimeton and Deseril.
and Depo-Medrol administered subconjunctivally once
a month. Systemic treatment with steroids has not been
necessary.
Case 2
A 12-year-old girl presented with recurrent bilateral
non-granulomatous uveitis, associated with a rising anti-
streptolysin titre and a streptococcal infection of her upper
TABLE Ill. RESULTS OF 8 CASES OF SEVERE UVEITIS TREATED WITH DESERIL AND CHLORTRIMETON
Patient Diagnosis Not controlled by Controlled by
Granulomatous panuveitis Prednisone Deseril
Lens-induced Depo-Medrol Chlortrimeton
Depo-Medrol
2 Non-granulomatous panuveitis Penicillin Deseril
Streptococcal infection Depo-Medrol Chlortrimeton
3 Non-granulomatous posterior uveitis Antibiotics Deseril
Ankylosing spondylitis Depo-Medrol Chlortrimeton
Prednisone
4 Non-granulomatous anterior uveitis Antibiotics Deseril
Streptococcal infection Depo-Medrol Chlortrimeton
5 Granulomatous panuveitis Prednisone Deseril
No cause found Antibiotics Chlortrimeton
Depo-Medrol (worsened)
6 Granulomatous panuveitis Antibiotics Deseril
Pyelonephritis Depo-Medrol (worsened) Chlortrimeton
7 Non-granulomatous posterior uveitis Depo-Medrol Deseril
No cause found Prednisone Chlortrimeton
Antibiotics
8 Granulomatous panuveitis Depo-Medrol (worsened) Deseril
No cause found Antibiotics Chlortrimeton
_~--,_IlI:;I;:l=============-------------------------------~
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respiratory tract. In spite of her tonsils having been re-
moved, long-term treatment with penicillin and systemic.
subconjunctival and local treatment with steroids, the
disease remained very active. She responded to Deseril
and Chlortrimeton. Steroids were withdrawn completely,
and her uveitis is being controlled with long-term treat-
ment with penicillin administered systemically. Deseril and
Chlortrimeton were discontinued after 3 months, and
the patient has not suffered a relapse for 8 months.
Other patients have been treated in the same way,
with similar results.
DISCUSSION
An initial attack of uveitis may be induced by a single
exposure to a large amount of antigen, which excites an
immune response. The antibody which is thus produced
combines with the antigen to form soluble circulating
immune complexes'" which are deposited at multiple sites,
including the eye, to cause immune complex uveitis,
(e.g. uveitis associated with serum sickness). However,
severe and recurrent attacks of uveitis are generally not
associated with systemic immune disease, while histological
examination of inflamed eyes shows large numbers of
immunocytes within the uveal tissues. These cells (small
Iymphocytes and plasma cells), which are known to remain
for long periods in tissue spaces, produce antibodies and
when triggered by fresh circulating antigen cause a severe
local inflammatory reaction on an immune basis.
These concepts suggested to us that patients with severe
or recurrent uveitis could be treated by preventing contact
of intravascular circulating antigen with immunocytes in
the interstitial fluid of the ocular tissues, through the use
of suitable antagonists of the vascular permeability factors.
Jncreased vascular permeability in inflammation" is induced
by mediators such as histamine, serotonin, kinins, acetyl-
choline and the prostaglandins. It is thought that these
mediators are activated in a definite sequence, starting
with histamine or serotonin, which are the mediators of
the immediate-type permeability response+-< and continuing
with kinins which seem to be the final mediators of the
delayed permeability response,'" and the prostaglandins,
which are associated with the later stages of more severe
grades of inflammation"· l •
Animal research in which auto-immune glomerulone-
phritis in rabbits was used as a model of inflammation has
demonstrated the involvement of histamine and serotonin
in deposition of antigen antibody con~plexes in immune
complex disease. Antagonists of these blood permeability
factors largely prevent acute immune complex disease in
the rabbit"'" and in man." ]n the chronic model of
immune complex disease in the rabbit"'" much greater
quantities of complexes become deposited in the kidneys
than in the acute mode!.16 Kniker has reported diminished
deposition of immune complexes with decrease in the
resultant injury after treatment with antagonists of hista-
mine and serotonin." We have used an antiserotonin,
methysergide maleate (Deseril) and an antihistamine,
chlorpheniramine maleate (Chlortrimeton), in cases where
steroids alone were ineffective.
In these desperate cases we have treated the patients
with ChJortrimeton and DeseriJ on a long-term basis
(3 - 12 months). These drugs are well tolerated and we
have had no serious side-effects. Deseril may produce
weakness, nausea, diarrhoea, angina, claudication, oedema,
tingling of extremities, psychosis and retroperitoneal
fibrosis. Chlortrimeton may cause drowsiness, dizziness,
dry mouth, nausea, headaches, muscular twitching, and
rarely hyperpyrexia. An alternative regimen with relatively
non-toxic cyproheptadine hydrochloride (Periactin) which
was also effective in rabbits but to a lesser degree than the
chlorpheniramine-methysergide combination," was tried,
but found to be useless in humans.
In conclusion, we wish to emphasise that while the
combination of antihistamine and a serotonin antagonist
is very effective in the special circumstances found in
cases of endogenous uveitis, it should be used with great
care in selected cases, especially when long-term adminis-
tration is contemplated.
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